rel-10-[(1R,2S)-2,3-Dihydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic Acid (>85%)
CAS: 151852-61-8
Ref. TR-D479540
5mg | 325.00 € | ||
25mg | 1,370.00 € | ||
100mg | 4,345.00 € |
Product Information
- 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid
- 10-[(1R,2S)-2,3-dihydroxy-1-(hydroxymethyl)propyl]-
- rel-
- 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid
- 10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]-
- (R*,S*)-(±)-
- rel-10-[(1R,2S)-2,3-Dihydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid
- 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid
- 10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]-
- (R*,S*)-
- See more synonyms
- 2,2',2''-[10-[(1RS,2SR)-2,3-Dihydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetic acid
Applications rel-10-[(1R,2S)-2,3-Dihydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic Acid is an intermediate in the synthesis of Calcobutrol (C145700), a new macrocyclic polyhydroxylated gadolinium chelate derivative which can be used as a contrast agent for Magnetic Resonance Imaging (MRI).
References Platzek, J. et al.: Inorg. Chem., 36, 6086 (1997);
Chemical properties
Technical inquiry about: TR-D479540 rel-10-[(1R,2S)-2,3-Dihydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic Acid (>85%)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.